Werkgroep Cardiologische centra Nederland
Menu

Emphasis (Completed)

A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines (EMPHASIS-HF)
Medicine
inspra (eplerenone)
Population
Heart failure
Phase
III
Starting year
2005
More information
ClinicalTrials.gov

Publications: Emphasis

  • Comparing LCZ696 with enalapril according to baseline risk using the MAGGIC and EMPHASIS-HF risk scores: an analysis of mortality and morbidity in PARADIGM-HF.J Am Coll Cardiol - Abstract - Mosterd, dr. A. - Emphasis - Heart failure

Publications by WCN study

Publications WCN studies by WCN member